Skip to main content
. 2020 Nov 2;34(11):461–469. doi: 10.1089/apc.2020.0145

Table 4.

Logistic Regressions Showing Associations Between Meeting All Outcome Measures and Demographics

Patient demographic All outcomes
Major outcomes
Laboratory outcomes
Anthropometric outcomes
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Sex                
 Female 0.73 (0.61–0.90) 0.84 (0.71–0.99) 0.65 (0.55–0.77) 1.45 (1.22–1.73)
 Male (Ref.)
Age, years                
 18–29 1.09 (0.68–1.74) 0.34 (0.24–0.50) 1.63 (1.13–2.33) 1.44 (1.00–2.08)
 30–49 0.94 (0.62–1.43) 0.51 (0.37–0.70) 1.25 (0.91–1.73) 1.32 (0.96–1.81)
 50–64 0.97 (0.64–1.45) 0.63 (0.46–0.86) 1.22 (0.89–1.66) 1.04 (0.77–1.40)
 ≥65 (Ref.)
Race/ethnicity                
 Asian 1.40 (0.69–2.84) 1.13 (0.63–2.04) 0.95 (0.53–1.71) 1.16 (0.60–2.26)
 Black 1.00 (0.79–1.27) 0.91 (0.75–1.11) 1.05 (0.86–1.28) 0.81 (0.65–1.01)
 Hispanic 1.26 (0.88–1.81) 1.19 (0.86–1.64) 1.11 (0.81–1.52) 1.57 (1.07–2.30)
 Other/unknown 1.16 (0.76–1.76) 0.82 (0.58–1.15) 0.70 (0.49–1.01) 0.61 (0.42–0.89)
 White (Ref.)
Coverage type                
 ACA marketplace 1.24 (0.96–1.60) 1.25 (1.00–1.55) 1.34 (1.08–1.67) 1.06 (0.84–1.33)
 Medicaid 0.42 (0.28–0.61) 0.46 (0.35–0.59) 0.81 (0.64–1.03) 0.79 (0.62–1.02)
 Medicare 0.53 (0.38–0.74) 0.47 (0.37–0.60) 0.81 (0.63–1.04) 0.93 (0.73–1.20)
 Commercial (Ref.)
Risk group                
 IDU 0.82 (0.62–1.08) 0.64 (0.52–0.80) 1.16 (0.93–1.43) 0.83 (0.66–1.04)
 MSM 1.02 (0.82–1.26) 0.96 (0.80–1.15) 1.04 (0.87–1.24) 1.32 (1.08–1.60)
 Other 0.77 (0.40–1.47) 0.66 (0.40–1.10) 0.71 (0.40–1.25) 0.94 (0.55–1.62)
 Unknown 0.75 (0.57–0.99) 0.74 (0.60–0.92) 0.74 (0.60–0.92) 0.89 (0.71–1.12)
 Heterosexual (Ref.)

Reference groups: male; age 65+ years; white, commercial, heterosexual. GEE is used to account for patients included in both time periods. Bold results indicate significance. Excludes BMI.